Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRYS
#874
Krystal Biotech, Inc. Common Stock
275.640
0
+1.85%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+1.85%
Monthly Change
-0.92%
6 month change
+47.30%
Cambio anual
+47.30%
Cierres anteriores
270.630
0
Open
275.640
0
Bid
Ask
Low
275.640
0
High
275.640
0
Volumen
67
Markets
Acciones
Atención Sanitaria
KRYS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
28.76 M
28.81 M
28.9 M
28.94 M
29 M
29.23 M
—
Valuation ratios
Enterprise value
4.86 B
4.17 B
4.9 B
3.62 B
4.73 B
6.71 B
19.96 B
Price to earnings ratio
87.51
52.22
43.24
27.88
26.43
36.04
133.59
Price to sales ratio
22.01
16.04
16.06
11.39
14.1
18.98
60.54
Price to cash flow ratio
68.81
37.75
38.72
20.94
29.86
36.76
126.28
Price to book ratio
1.6
4.92
1.46
1.06
1.28
6.05
9.86
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.04
0.03
0.03
0.06
0.04
0.17
Return on equity %
0.03
0.05
0.04
0.04
0.07
0.04
0.19
Return on invested capital %
22.21
25.02
26.31
28.8
35.93
35.83
126.87
Gross margin %
100
100
100
100
100
100
400
Operating margin %
26.76
30.69
41.02
40.93
42.3
41.49
165.75
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
32.42
49.9
40.52
39.91
81.15
47.99
209.57
Liquidity ratios
Quick ratio
7.76
7.02
9.27
9.33
9.73
9.56
37.88
Current ratio
7.97
7.28
9.65
9.68
10.14
9.95
39.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.09
0.09
0.08
0.09
0.08
0.08
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.97
1.78
1.04
1.77
1.33
2.59
6.73
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
19.67
20.09
20.65
22.93
24.51
27.64
95.72
Net current asset value per share
23.85
24.95
25.67
28.28
31.03
34.21
119.19
Tangible book value per share
29.62
31.82
32.96
34.98
38.14
40.72
146.81
Working capital per share
20.86
21.52
23.01
25.36
27.97
30.77
107.11
Book value per share
29.62
31.82
32.96
34.98
38.14
40.72
146.81
Noticias
Director de Krystal Biotech Janney vende acciones por 10,1 millones de dólares
Director de Krystal Biotech Janney vende acciones por $10.1 millones
Krystal Biotech director Janney sells shares worth $10.1 million
Director de Krystal Biotech (KRYS) vende acciones por 4,95 millones de dólares
Director de Krystal Biotech (KRYS) vende acciones por $4.95 millones
Krystal Biotech (KRYS) director Rossi sells shares worth $4.95 million
AI Play SPX Leads 17 Top Performers Onto Best Stock Screens Like IBD 50, Stock Spotlight, More
Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark
Dow Jones Futures Fall After Market Reverses Higher; Meta Deal Lifts Nvidia, Hits AI Rivals
Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings Call Transcript
Las acciones de Krystal Biotech alcanzan máximos históricos en 296,78 dólares
Acción de Krystal Biotech alcanza un máximo histórico en 296.78 USD